My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Troglitazone-associated hepatotoxicity treated successfully with steroids.

    Prendergast KA, Berg CL, Wisniewski R.

    Ann Intern Med. 2000 Nov 7;133(9):751. No abstract available. PMID: 11074925 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fatal hepatotoxicity associated with troglitazone.

    Vella A, de Groen PC, Dinneen SF.

    Ann Intern Med. 1998 Dec 15;129(12):1080. No abstract available. PMID: 9867776 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.

    Gitlin N, Julie NL, Spurr CL, Lim KN, Juarbe HM.

    Ann Intern Med. 1998 Jul 1;129(1):36-8. No abstract available. PMID: 9652997 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Troglitazone-associated hepatic failure.

    Misbin RI.

    Ann Intern Med. 1999 Feb 16;130(4 Pt 1):330. No abstract available. PMID: 10068399 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hepatotoxicity of the thiazolidinediones.

    Tolman KG, Chandramouli J.

    Clin Liver Dis. 2003 May;7(2):369-79, vi. Review.PMID: 12879989 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rapid-onset subfulminant liver failure associated with troglitazone.

    Jagannath S, Rai R.

    Ann Intern Med. 2000 Apr 18;132(8):677. No abstract available. PMID: 10766693 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Substituting for troglitazone (Rezulin).

    [No authors listed]

    Med Lett Drugs Ther. 2000 Apr 17;42(1076):36. No abstract available. PMID: 10803176 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hepatic injury due to troglitazone.

    Malik AH, Prasad P, Saboorian MH, Thiele DL, Malet PF.

    Dig Dis Sci. 2000 Jan;45(1):210-4. Review. No abstract available. PMID: 10695637 [PubMed - indexed for MEDLINE]Related articles

    9.

    Efficacy and safety of troglitazone for lipodystrophy syndromes.

    Caldwell SH.

    Ann Intern Med. 2001 May 15;134(10):1008. No abstract available. PMID: 11352703 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Troglitazone-associated hepatic failure.

    Booth AM, Caldwell SH, Iezzoni JC.

    Am J Gastroenterol. 2000 Feb;95(2):557-8. No abstract available. PMID: 10685776 [PubMed - indexed for MEDLINE]Related articles

    11.

    Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.

    Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B.

    Dig Dis Sci. 2002 Jul;47(7):1632-7.PMID: 12141828 [PubMed - indexed for MEDLINE]Related articles

    12.

    Did this drug cause my patient's hepatitis?

    Kaplowitz N, Lewis JH, Watkins PB.

    Ann Intern Med. 2003 Jan 21;138(2):159-60; author reply 159-60. No abstract available. PMID: 12529106 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Hepatotoxicity with thiazolidinediones: is it a class effect?

    Scheen AJ.

    Drug Saf. 2001;24(12):873-88. Review.PMID: 11735645 [PubMed - indexed for MEDLINE]Related articles

    14.

    Severe but reversible hepatitis induced by troglitazone.

    Schiano T, Dolehide K, Hart J, Baker AL.

    Dig Dis Sci. 2000 May;45(5):1039-42. No abstract available. PMID: 10795774 [PubMed - indexed for MEDLINE]Related articles

    15.

    Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings.

    Li H, Heller DS, Leevy CB, Zierer KG, Klein KM.

    J Diabetes Complications. 2000 May-Jun;14(3):175-7.PMID: 10989325 [PubMed - indexed for MEDLINE]Related articles

    16.

    Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin.

    Caldwell SH, Hespenheide EE, von Borstel RW.

    Dig Dis Sci. 2001 Feb;46(2):376-8.PMID: 11281188 [PubMed - indexed for MEDLINE]Related articles

    17.

    A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.

    Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T.

    Clin Pharmacol Ther. 2003 May;73(5):435-55.PMID: 12732844 [PubMed - indexed for MEDLINE]Related articles

    18.

    Rules and laws of drug hepatotoxicity.

    Kaplowitz N.

    Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):231-3. No abstract available. PMID: 16552791 [PubMed - indexed for MEDLINE]Related articles

    19.

    Severe hepatotoxicity associated with troglitazone.

    Herrine SK, Choudhary C.

    Ann Intern Med. 1999 Jan 19;130(2):163-4. No abstract available. PMID: 10068372 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Troglitazone (Rezulin) and hepatic injury.

    Faich GA, Moseley RH.

    Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):537-47.PMID: 11828837 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity